Eduardo Burgarelli Lages (Eduardo B Lages)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Health Information

Cognitive Decline

Top Venues

Nanomedicine (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Gabriel Silva Marques Borges, Eduardo Burgarelli Lages, Gisele Assis Castro Goulart, Lucas Antônio Miranda Ferreira
Nanoencapsulated all- trans retinoic acid as an adjuvant for mucosal vaccines. Nanomedicine (London, England) (2023)
Eduardo Burgarelli Lages, Gabriel Silva Marques Borges, Lucas Antônio Miranda Ferreira
Novel formulation approaches for synergistic codelivery based on lipid nanocarriers. Nanomedicine (London, England) (2023)
Bruna Rodrigues Dias Assis, Isabela Pereira Gomes, Júlia Teixeira de Castro, Graziella Gomes Rivelli, Natália Salazar de Castro, Diana Paola Gomez-Mendoza, Flávia Fonseca Bagno, Natália Satchiko Hojo-Souza, Ana Luiza Chaves Maia, Eduardo Burgarelli Lages, Flavio Guimarães da Fonseca, Santuza Maria Ribeiro Teixeira, Ana Paula Fernandes, Ricardo Tostes Gazzinelli, Gisele Assis Castro Goulart
Quality attributes of CTVad1, a nanoemulsified adjuvant for phase I clinical trial of SpiN COVID-19 vaccine. Nanomedicine (London, England) (2023)
Ana P Araujo de Oliveira, Victoria C Romero Colmenares, Renata Diniz, Jennifer T J Freitas, Clara M da Cruz, Eduardo Burgarelli Lages, Lucas A M Ferreira, Rafael P Vieira, Heloisa Beraldo
Memantine-Derived Schiff Bases as Transdermal Prodrug Candidates. ACS omega 7 (14) (2022)
Eduardo Burgarelli Lages, Gabriel Silva Marques Borges, Gisele Assis Castro Goulart, Lucas Antônio Miranda Ferreira
Nanomedicine to deliver docosahexaenoic acid: potential applications to improve health. Nanomedicine (London, England) 16 (18) (2021)
Cristiane M Pinto, Laila S Horta, Amanda P Soares, Bárbara A Carvalho, Enio Ferreira, Eduardo Burgarelli Lages, Lucas A M Ferreira, André Augusto Gomes Faraco, Helton C Santiago, Gisele A C Goulart
Nanoencapsulated Doxorubicin Prevents Mucositis Development in Mice. Pharmaceutics 13 (7) (2021)